Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia.
about
Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatmentThe Effectiveness of Transcranial Brain Stimulation in Improving Clinical Signs of Hyperkinetic Movement DisordersFunctional neuroimaging in Parkinson's diseaseWorsening of levodopa-induced dyskinesias by motor and mental tasksDopaminergic modulation of the updating of stimulus-response episodes in Parkinson's disease.Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signalingMedication-Induced Tardive Dyskinesia: A Review and Update.The acute brain response to levodopa heralds dyskinesias in Parkinson disease.Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.Interactions of CaMKII with dopamine D2 receptors: roles in levodopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson's ratsTreatment of Parkinson's disease by cortical stimulation.Role of the primary motor cortex in L-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation.Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease.Parkinson's disease and healthy aging: independent and interacting effects on action selection.Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype?Motor cortex stimulation in Parkinson's disease.Noninvasive brain stimulation for Parkinson's disease and dystonia.Maladaptive plasticity in levodopa-induced dyskinesias and tardive dyskinesias: old and new insights on the effects of dopamine receptor pharmacologyPerspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease.Changes in brain functional activation during resting and locomotor states after unilateral nigrostriatal damage in rats.GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic ratsDorsolateral prefrontal cortex: a possible target for modulating dyskinesias in Parkinson's disease by repetitive transcranial magnetic stimulation.The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease.Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.Disruption of information processing in the supplementary motor area of the MPTP-treated monkey: a clue to the pathophysiology of akinesia?Pharmacologically modulated fMRI--cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients.Targeted motor rehabilitation dissociates corticobulbar versus corticospinal dysfunction in an animal model of Parkinson's disease.Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease.Can levodopa-induced dyskinesias go beyond the motor circuit?A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias.Is executive control used to compensate for involuntary movements in levodopa-induced dyskinesia?Transcranial Non-Invasive Brain Stimulation in Parkinson's Disease Patients with Dyskinesias. Where is the Optimal Target?Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias.Therapy for dyskinesias in Parkinson’s disease patients
P2860
Q24647141-8D158CB8-C520-422B-9EF8-413AF0BD653DQ26771539-E78DF010-89AD-4925-AB2E-85F5B49027B5Q27013767-300B0113-E789-4299-A45A-BAF6EA5B6932Q28372142-C57FBA79-06CD-4EE3-82AC-E3D46ABFAE38Q30419262-20025B85-04C5-49F6-B77A-6ACACCE4F292Q30594829-1481E823-3DDF-42D7-B859-76A108EA1D56Q30833645-EAD6DE6B-E4BC-4C89-8BB1-F5075D0755D9Q33428476-FAA7BDEA-B3C2-4C2A-AEF5-A9182D5D2890Q33802645-27EBD273-07D0-49FE-897C-01577C583E20Q33957877-30D53B0D-55B9-4015-8528-4842FC3549DCQ34325365-F8DB1D9A-DD9F-4389-A5FC-356E5544EA45Q34417485-9145EF06-F0C1-4F3D-8DCC-F25006F734B7Q35015442-22DAD20A-FFE2-4A17-B8D8-B0BB52D43CE9Q35087525-24689CBC-F7B1-4930-93C0-9BD6ECED9929Q35683102-42228043-7BE8-4784-BA04-37F097C3F65AQ35963542-3CF572B9-70D3-481F-BBEC-80C000935EF9Q36241219-3461FC6F-A25D-49C4-B444-15BB183C525CQ36418031-D11699C2-27D2-47D3-AE61-A4600421F15AQ37131286-3F8511B0-E018-4E02-AC0A-972E0A95BDACQ37705423-8DF37F4F-4891-4E09-9BF7-22810AA77D2CQ38099828-F4F6CF66-A30A-4B85-8877-8964A56FC9E9Q40216082-AFBA8C13-1E32-4B8A-BD2F-264B4C417E0BQ40789803-CDD92E45-9EFF-437D-8B50-0FA184434A8DQ41935713-E36FB613-0020-4477-8CBB-45A139218D10Q42486325-3AAFC391-B513-483F-B635-03CD6E61C1CFQ42830127-2F493975-63B3-450E-ACAC-2038C7762EAAQ44246018-9C2A7174-1EB7-45DD-B4BC-ADD70128B674Q44285192-0F80C400-0EE7-4AFD-B81C-45267958D1A4Q46347751-D5359D65-700D-4FF7-9C6D-1DA39F4F8CC6Q47355738-DEEB026C-2DAF-4A47-B5EA-68FBB53F9090Q48357239-9F539C87-DC06-4E23-9EC1-E3A136A6EB58Q48450734-6EB5C7F2-FC25-4594-B2BD-7F23078E2B80Q48617765-674F4A60-D145-4795-963D-F622F892DBB0Q48869513-241E5718-8440-4EA4-B997-A0926ADC24A8Q48918092-2A755E91-A533-44CA-AE40-13E82146B593Q57518128-74C3348F-7C22-4F8D-83DA-9249DBC83C39
P2860
Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Cortical motor overactivation ...... -induced peak-dose dyskinesia.
@en
Cortical motor overactivation ...... -induced peak-dose dyskinesia.
@nl
type
label
Cortical motor overactivation ...... -induced peak-dose dyskinesia.
@en
Cortical motor overactivation ...... -induced peak-dose dyskinesia.
@nl
altLabel
Cortical motor overactivation ...... - induced peak-dose dyskinesia
@en
prefLabel
Cortical motor overactivation ...... -induced peak-dose dyskinesia.
@en
Cortical motor overactivation ...... -induced peak-dose dyskinesia.
@nl
P2093
P356
P1433
P1476
Cortical motor overactivation ...... a-induced peak-dose dyskinesia
@en
P2093
G Viallard
J L Montastruc
P304
P356
10.1093/BRAIN/121.3.527
P407
P478
121 ( Pt 3)
P577
1998-03-01T00:00:00Z